US Map / Nebraska
State NE

Clinical Trials in Nebraska

Nebraska is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Nebraska and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 102 actively recruiting studies with Nebraska sites out of 102 registered in total. The busiest research areas in Nebraska are Heart Failure, Multiple Myeloma, Prostate Cancer. Leading sponsors running trials in the state include AstraZeneca, University of Nebraska, National Cancer Institute (NCI). By stage, Nebraska trials break down as Phase 1 (14), Phase 2 (27), Phase 3 (42), Phase 4 (4).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
102
Recruiting Now
102
← Back to US Map
Top Conditions in Nebraska
Heart Failure (4)Multiple Myeloma (3)Prostate Cancer (3)Ovarian Cancer (3)Asthma (2)Schizophrenia (2)Healthy (2)Colorectal Cancer (2)Metastatic Castration-resistant Prostate Cancer (2)Mesothelioma (2)Untreated, Unresectable, or Metastatic Colorectal Cancer (1)Pareses (1)

Frequently Asked Questions — Clinical Trials in Nebraska

How many clinical trials are currently recruiting in Nebraska?
ClinicalMetric currently tracks 102 actively recruiting clinical trials with at least one location in Nebraska. The total number of registered studies—including active but not currently enrolling trials—is 102. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Nebraska?
Nebraska hosts clinical trials across a broad range of medical conditions, including Heart Failure, Multiple Myeloma, Prostate Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Nebraska serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Nebraska?
To join a clinical trial in Nebraska, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Nebraska maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Nebraska

NCT04329728 Phase 1, Phase 2
Recruiting
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Condition
Lymphoid Malignancies
Enrollment
144 pts
Location
United States
Sponsor
AVM Biotechnology Inc
View Trial →
NCT05261139 Phase 3
Recruiting
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatr...
Condition
COVID-19
Enrollment
160 pts
Location
United States, Bulgaria, Japan
Sponsor
Pfizer
View Trial →
Page 5 of 5 — 102 trials total
← Prev
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology